There is circumstantial but impressive evidence that natural cytotoxic (NC) activity is involved in host protection against cancer. This study is designed to analyze the relationship of NC activity to tumorigenicity such that realistic limits can be set on the efficiency of any NC tumor-surveillance system. Although NC and NK (nstural killer) activities have much in common, it has now been established that the NC and NK lytic mechanisms, and how cells avoid lysis by these mechanisms, are fundamentally different and, therefore, what is known about NK activity does not necessarily extend to the NC system. This analysis of NC activity and tumorigenicity is divided into two main sections: (1) the determination of the efficiency of NC activity as a tumor surveillance mechanism. This will determine how significant NC surveillance is as a defense against cancer; and (2) the analysis of how tumors avoid NC lysis in order to grow in vivo. This will provide basic knowledge about the interaction between tumors and host protective mechanisms, and may eventually provide a rational approach for manipulating those interactions. Our research will determine the upper limit of the efficiency of NC activity as a tumor surveillance mechanism by determining the correlation between malignant transformation and NC sensitivity. In addition, research will determine if that correlation is influenced by the tissue origin of the transformed cells or by the type of carcinogen used for transformation, how variants of these cells eacape from NC lysis, and if escape is sufficient to increase tumorigenicity. Recently, an obtained cloned cell line showed it had NC activity. Our research will develop this technology to facilitate not only our experiments but those of others as well. (HF)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA034805-03
Application #
3172635
Study Section
Immunobiology Study Section (IMB)
Project Start
1984-08-01
Project End
1988-05-31
Budget Start
1986-08-01
Budget End
1988-05-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Sasaki, C Y; Patek, P Q (1994) Inhibition of tumor necrosis factor-mediated lysis by spleen cell-conditioned medium. Int J Immunopharmacol 16:301-9
Patek, P Q; Lin, Y (1991) In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity. J Immunol 146:3457-61
Patek, P Q; Lin, Y (1989) Natural cytotoxic activity is not necessarily mediated by the release of tumour necrosis factor. Immunology 67:509-13
Patek, P Q; Lin, Y; Case, P G (1989) Cell lines cultured at high density are resistant to lysis by tumor necrosis factor and natural cytotoxic cells. Proc Soc Exp Biol Med 190:234-9
Patek, P Q; Collins, J L (1988) Tumor surveillance revisited: natural cytotoxic (NC) activity deters tumorigenesis. Cell Immunol 116:240-9
Lin, Y; Case, P G; Patek, P Q (1988) Inhibition of tumour necrosis factor and natural cytotoxic cell lytic activities by a spleen cell-elaborated factor. Immunology 63:663-8
Patek, P Q; Lin, Y; Collins, J L (1987) Natural cytotoxic cells and tumor necrosis factor activate similar lytic mechanisms. J Immunol 138:1641-6
Patek, P Q; Lin, Y; Collins, J L et al. (1986) In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity. J Immunol 136:741-5
Collins, J L; Patek, P Q; Lin, Y et al. (1986) The cloned cell line L10A2.J expresses natural cytotoxic activity. Cell Immunol 103:191-8
Collins, J L; Lin, Y; Patek, P Q (1986) Dissociation of contact-noninhibition in vitro and tumorigenicity in vivo. Cell Biol Int Rep 10:789-96

Showing the most recent 10 out of 11 publications